Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RASBURICASE Cause Product preparation issue? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Product preparation issue have been filed in association with RASBURICASE (Elitek). This represents 0.6% of all adverse event reports for RASBURICASE.

5
Reports of Product preparation issue with RASBURICASE
0.6%
of all RASBURICASE reports
0
Deaths
0
Hospitalizations

How Dangerous Is Product preparation issue From RASBURICASE?

Of the 5 reports.

Is Product preparation issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RASBURICASE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does RASBURICASE Cause?

Tumour lysis syndrome (116) Methaemoglobinaemia (92) Off label use (90) Product use in unapproved indication (76) Bacterial infection (75) Fungal infection (73) Cellulitis (72) Clostridium difficile colitis (72) Lymphoid tissue hypoplasia (72) Lymphopenia (72)

What Other Drugs Cause Product preparation issue?

ONABOTULINUMTOXINA (677) COAGULATION FACTOR IX HUMAN\COAGULATION FACTOR VII HUMAN\COAGULATION FACTOR X HUMAN\PROTEIN C\PROTEIN S HUMAN\PROTHROMBIN (252) HUMAN C1-ESTERASE INHIBITOR (238) SOMATROPIN (200) INCOBOTULINUMTOXINA (174) STIRIPENTOL (129) TESAMORELIN (119) ABATACEPT (115) INFLIXIMAB (101) ABOBOTULINUMTOXINA (91)

Which RASBURICASE Alternatives Have Lower Product preparation issue Risk?

RASBURICASE vs RAVULIZUMAB RASBURICASE vs RAVULIZUMAB-CWVZ RASBURICASE vs REBAMIPIDE RASBURICASE vs REBETOL RASBURICASE vs REBIF

Related Pages

RASBURICASE Full Profile All Product preparation issue Reports All Drugs Causing Product preparation issue RASBURICASE Demographics